Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World
2021 · JACC. Cardiovascular imaging · 39 citations
https://doi.org/10.1016/j.jcmg.2021.03.007
T
Toshiaki Kadokami
Social Welfare Organization Saiseikai Imperial Gift Foundation(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
138
Papers
2.8K
Citations
28
h-index
52
i10-index
Toshiaki Kadokami is an academic researcher from Social Welfare Organization Saiseikai Imperial Gift Foundation. The author has contributed to research in topics: Cardiac Imaging and Diagnostics & Diabetes Treatment and Management & Heart Failure Treatment and Management. The author has an h-index of 28, co-authored 118 publications.
ORCID: 0000-0001-9017-700XPapers by this author
worksWorldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19
2022 · Journal of the American College of Cardiology · 29 citations
https://doi.org/10.1016/j.jacc.2022.03.348
Rationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study
2016 · Cardiovascular Diabetology · 28 citations
https://doi.org/10.1186/s12933-016-0449-7
Effect of febuxostat on left ventricular diastolic function in patients with asymptomatic hyperuricemia: a sub analysis of the PRIZE Study
2021 · Hypertension Research · 15 citations
https://doi.org/10.1038/s41440-021-00752-9
Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia
2021 · JACC Asia · 13 citations
https://doi.org/10.1016/j.jacasi.2021.06.002
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
2023 · Cardiovascular Diabetology · 7 citations
https://doi.org/10.1186/s12933-023-01856-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat